Evidence map›Paper›PMID 35971170›Full record

ArticleBMC veterinary research2022

The efficacy of metal nanocomposite (Fe

Nagla F Al Shap, Eman M El El-Sherbeny, Dalia M A El Masry

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nagla F Al ShapToxicology Unit Animal Health Research Institute, Tanta lab.Agricultural Research Center (ARC), Giza, Egypt.
Eman M El El-SherbenyPharmacology Unit Animal Health Research Institute, Tanta lab. Agricultural Research Center (ARC), Giza, Egypt.
Dalia M A El MasryNanomaterials Research and Synthesis Unit, Animal Health Research Institute, Agricultural Research Center (ARC), Giza, 264, Egypt. dr_daliaelmasry@ahri.gov.eg.
Agricultural Research Center · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aimed to investigate the effectiveness of different doses of metal nanocomposite (MNc) (Fe

resultsBody weight gain and heamatocellular elements in both treated groups increased significantly than control. Serum phagocytic nitric oxide levels were increased significantly in both treated groups than control groups. Prothrombin time (PT), Alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) activities decreased significantly (P < 0.05) in both treated groups than intoxicated control group (G2) but still higher than non-intoxicated control group (G1). Total protein, albumin, globulin, calcium and phosphorus increased significantly in both treated groups than intoxicated control group. Kidney function tests showed significant improvement in both treated groups than intoxicated control group. Antioxidant study revealed that malondialdehyde (MDA) decreased significantly in treated groups than intoxicated control group. Ochratoxin residue decreased significantly in treated groups. Metal residues in tested liver and muscle of treated groups showed no-significant difference with non-intoxicated control group (G1) at the experiment's end. In conclusion, feeding either low or high doses of MNc to broilers were significantly counteracting the negative impacts of OTA or its residue and increase their body weight.

Indexed as

NanocompositesOchratoxinsZinc OxideAnimal FeedAnimalsChickensCopperWeight GainCoppercupric oxideOchratoxinsZinc OxideChicken body weightLiver and kidney functionMetal and ochratoxin-residueMetal nanocomposite Fe3O4/CuO/ZnOTotal leucocytic count

Identifiers

PMID35971170
PMCPMC9377104
OpenAlexW4291383181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.